Vijaya Diagnostic Centre
987.40
+16.30(+1.68%)
Market Cap₹9,975.60 Cr
PE Ratio67.32
Company Performance:
1D+1.68%
1M-5.72%
6M-1.29%
1Y-8.16%
5Y+59.23%
View Company Insightsright
More news about Vijaya Diagnostic Centre
08Jul 25
Vijaya Diagnostic Centre Ltd. Sees Rs. 23.13 Crore Block Trade on NSE
A significant block trade of 230,405 shares of Vijaya Diagnostic Centre Ltd. was executed on the National Stock Exchange (NSE). The transaction was valued at Rs. 23.13 crore, with each share priced at Rs. 1,004.00. This large trade indicates potential shifts in ownership or strategic moves by major shareholders, although the identities of the buyer and seller remain undisclosed. Such transactions can influence market sentiment and the stock's trading pattern in the short term.
12May 25
Vijaya Diagnostic Centre Reports Q4 Growth in EBITDA and Net Profit, Declares Dividend
Vijaya Diagnostic Centre's Q4 results show significant growth across key financial metrics. Revenue increased by 26.05% to ₹173.70 crore, EBITDA rose by 29.60% to ₹71.80 crore, and net profit grew by 35.77% to ₹35.30 crore year-over-year. The company's EBITDA margin improved to 41.34%, and it declared a dividend of ₹2.00 per share. Operating profit reached ₹67.10 crore with a margin of 39.73%, indicating strong core operational performance.
Vijaya Diagnostic Centre
987.40
+16.30
(+1.68%)
1 Year Returns:-8.16%
Industry Peers
Dr. Lal Path Labs
3,122.40
(-1.69%)
Metropolis Healthcare
1,941.70
(-0.78%)
Thyrocare Technologies
1,238.70
(-2.05%)
Krsnaa Diagnostics
832.45
(+0.36%)
Suraksha Diagnostic
295.15
(+1.34%)
3B BlackBio DX
1,372.10
(-1.28%)
Sastasundar Ventures
310.15
(-0.14%)
Choksi Laboratories
166.40
(-7.40%)